We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.00
Bid: 37.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.405%)
Open: 38.00
High: 38.00
Low: 38.00
Prev. Close: 38.00
MIG1 Live PriceLast checked at -
Maven Income and Growth VCT is an Investment Trust

To achieve long term capital appreciation and generate maintainable levels of income for shareholders through investing in small and medium sized unlisted and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

7 Jun 2012 18:00

RNS Number : 9428E
Maven Income & Growth VCT PLC
07 June 2012
 



Maven Income and Growth VCT PLC

 

Final results for the year ended 29 February 2012

 

The Directors are pleased to report the Company's financial results for the year ended 29 February 2012.

 

Chairman's Statement

 

The Board is pleased to report that the year to 29 February 2012 has seen positive progress in Shareholder returns, with further expansion of the portfolio and a continued focus on making later-stage, income producing private company investments. This strong performance has been achieved against a background of persistent economic uncertainty and a challenging trading environment for the UK smaller company sector.

 

The key objective for your Company is to generate long-term capital growth and maintainable levels of tax-free income, by investing only in mature cash generative private companies, on prudent entry multiples. This investment approach has allowed your Company to build a widely diversified portfolio and deliver growth in NAV for Shareholders, while paying an increasing level of tax-free dividends.

 

Overall your Board is encouraged by the progress being made by your Company, which validates the investment strategy, and has noted recent market analysis which reflects the success of that approach. The Manager's ability to identify high growth private company assets was highlighted in the Deloitte Buyout Track 100 report in February 2012. Four of your Company's existing portfolio investments feature in this report, which tracks the performance of the top 100 private equity backed medium-sized companies in Britain over the past two years.

 

The highlights of the year under review are:

 

·; NAV total return of 112.0p per share (2011: 104.4p) at year end, up 7.3%;

 

·; NAV of 67.9p per share (2011: 65.3p);

 

·; five new later-stage high yielding private company investments completed, with two further holdings acquired after the period end;

 

·; disposal of Walker Technical Resources for a total return of 3.0 times original investment cost, with two further profitable exits completed after the period end; and

 

·; a final dividend proposed of 3.5p per share, comprising 0.5p revenue and 3.0p capital, to make a total of 5.0p for the year.

 

Performance

 

The NAV total return per share at 29 February 2012 was 112.0p, an increase of 7.3% over the equivalent figure at 28 February 2011. The most important measure of performance for a VCT is the NAV total return, being the long-term record of dividend payments out of income and capital gains combined with the current NAV. In the short term, the NAV in isolation is a less important measure of performance as the underlying investments are long-term in nature and not readily realisable. At 29 February 2012, the NAV per Ordinary Share was 67.9p.

 

VCT qualifying status

 

The Company is required to meet the VCT qualifying criteria on a continuous basis. The Board regularly reviews the status of these criteria and is pleased to confirm that all tests have continued to be met.

 

Dividends

 

The Board is proposing a final dividend of 3.5p per share, comprising 0.5p of revenue and 3.0p of capital, to be paid on 20 July 2012 to Shareholders on the register at close of business on 22 June 2012. Including the interim dividend of 1.5p per share paid in December 2011, the total tax-free yield is 8.7% based on the share price of 57.25p at the year end, which is equivalent to 11.6% on a taxable UK equity investment for a 40% tax payer. The effect of paying the proposed final dividend of 3.5p will be to reduce the NAV per Ordinary Share to 64.4p.

 

Investment strategy

 

Your Company's strategy is to invest in a broadly based portfolio of income producing later-stage UK private companies across a range of industry sectors, while also looking to achieve significant regional diversification.

 

 

The Manager has a nationwide office network, with six regionally based teams which are introduced to a wide range of prospective private company transactions each year. Each potential investment is carefully scrutinised and subject to strict selection criteria. New investments will only be made where businesses are available at conservative entry prices, in transactions typically structured with a significant element of secured loan stock in order to generate an immediate high yield.

 

The structured exit from the AIM/PLUS portfolio has also continued during the year, with a number of further disposals made to realise cash to fund the expansion of the private company portfolio. The Board and the Manager take the view that the potential returns available from AIM and PLUS quoted investments remain too uncertain at the current time and, at the period end, these represented less than 2% of the portfolio by value.

 

The Listing Rules require your Board to ensure that this Report includes information on the investment policy, including a description of the asset mix, the spread of risk and maximum exposures. This information is contained in the Directors' Report and in the various tabular analyses of the portfolio.

 

Principal risks and uncertainties

 

The Board has reviewed the principal risks and uncertainties facing the Company for the financial year. In order to minimise the exposure to investment risk, the Company has invested in a broadly-based portfolio of holdings in private and AIM or PLUS quoted companies in the UK.

 

Valuation process

 

Investments held by Maven Income and Growth VCT in unquoted companies are valued in accordance with the International Private Equity And Venture Capital Valuation Guidelines.

 

Investments quoted or traded on a recognised stock exchange, including the Alternative Investment Market (AIM), are valued at their bid prices.

 

Portfolio developments

 

During the year there were five new and eight follow-on investments completed, and the Manager has also invested in two new private companies since the year end. In line with the strategy of investing only in established cash-generative businesses, each of the new assets has little or no bank or other external debt and is forecast to generate substantial levels of income from the outset. The private equity portfolio is generally performing well, with most companies trading at or ahead of plan. The increasing maturity of a number of holdings is also leading to the emergence of M&A interest in several existing portfolio companies, and the Manager is currently working on a number of potential exits, although there can be no certainty that these will ultimately lead to profitable disposals.

 

The Board is pleased to report that there have been three profitable private company exits for the Company, including two after the year end. The realisation of Walker Technical Resources in July 2011 achieved a 3.0 times total return on the initial investment cost, whilst the exit from ATR Group in March 2012 realised a return of 1.7 times investment cost. More significantly, the disposal of the holding in TPL (Midlands) Limited (trading as Transys Projects) was completed in early June 2012. For contractual reasons the Directors are not able to publish specific details of the transaction, which has not been reflected in the Financial Statements for the year ended 29 February 2012. However, as a result, there will be an increase of approximately 4.7p per share in the net asset value of the Company, representing an uplift of 6.9% on the year-end figure.

 

Share buy-backs

 

The Company has bought back a total of 495,000 shares for cancellation throughout the year. Buying these shares in the market created some liquidity and the discount had narrowed to 15.7% at the year end. At the forthcoming AGM, the Company will again seek the authority of Shareholders to continue to buy back shares in the market.

 

Recovery of VAT

 

The Board has continued its dialogue with Aberdeen Asset Management PLC (Aberdeen) with a view to making further recovery of VAT paid previously by the Company in respect of investment management fees. An offer of £118,425 in respect of VAT paid during the period from 28 June 2004 to 30 September 2005, plus interest of £18,585, was received and accepted as final settlement on the basis that the Company will remain entitled to any additional VAT and interest recovered from HMRC by Aberdeen. The receipt of these amounts has been reflected in the Financial Statements.

 

 

 

 

 

Co-investment scheme of the Manager

 

The co-investment scheme, which allows executive members of the Manager to invest alongside the Company, continued in operation during the year. The scheme operates through a nominee company which participates in every transaction completed by the Company, including any follow-on investments. The scheme closely aligns the interests of the executives and the Company's Shareholders, while providing an incentive to enable the Manager to retain the existing skills and capacity of the investment team in what is a competitive market for talent.

 

Share capital and fund raising

 

In the period to 3 May 2011 your Company raised additional funds through a linked VCT Top-up Offer with Maven Income and Growth VCT 2, Maven Income and Growth VCT 3 and Maven Income and Growth VCT 4. Net proceeds of £912,000 were raised, after deduction of costs, and 1,511,929 new shares were issued.

 

In December 2011 your Board announced a further Top-up Offer for Subscription, in parallel with similar Offers by Maven Income and Growth VCT 2, Maven Income and Growth VCT 3 and Maven Income and Growth VCT 4, with each Company aiming to raise £1.25 million before expenses (this amount being within the maximum permitted under the Prospectus Rules and avoiding the Company having to incur the higher costs associated with publishing a full prospectus). I am pleased to report that the Offer was oversubscribed and closed early on 1 March 2012, which in the view of the Board is a positive reflection of the Manager's generalist strategy that has produced improved Shareholder returns in recent years.

 

The monies raised under such Offers may be used by the Company to pay dividends and cover general running costs, which has the advantage of preserving for investment purposes an equivalent sum of valuable 'old money' which operates under more flexible VCT regulations. The proceeds will also provide additional liquidity for the Company to make more later-stage investments, and allow it to spread its costs over a larger asset base to the benefit of all Shareholders.

 

Outlook

 

The Company is well placed to continue to achieve attractive long-term tax-efficient returns, by deploying capital in sensibly priced mature private company assets capable of delivering long-term capital appreciation. The private company portfolio continues to generate strong revenues for your Company in support of a sustainable dividend programme, and your Board believes that the later stage investment strategy employed by the Manager will produce ongoing improvements in Shareholder returns.

 

John Pocock

Chairman

17 June 2011

 

 

 

Maven Income and Growth VCT PLC

Income Statement

For the year ended 29 February 2012

Year ended

29 February 2012

Year ended

28 February 2011

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

Investment income and deposit interest

1,478

-

1,478

864

-

864

Investment management fees

(163)

(653)

(816)

(92)

(367)

(459)

Other expenses

(213)

-

(213)

(345)

-

(345)

Gains on investments

-

2,636

 2,636

-

2,599

2,599

Net return on ordinary activities before taxation

1,102

1,983

 3,085

427

 2,232

2,659

Tax on ordinary activities

(234)

159

(75)

(76)

76

-

Return attributable to Equity Shareholders

868

2,142

 3,010

351

2,308

2,659

Earnings per share (pence)

2.2

5.4

7.6

0.9

6.1

7.0

 

A Statement of Total Recognised Gains and Losses has not been prepared, as all gains and losses are recognised in the Income Statement.

 

The total column of this statement is the Profit and Loss Account of the Company.

 

Reconciliation of Movements in Shareholders' Funds

 

For the year ended 29 February 2012

 

Year ended

29 February 2012

Year ended

28 February 2011

£'000

£'000

Opening Shareholders' funds

24,964

21,797

Net return for year

3,010

2,659

Proceeds of 2010 share issue

-

1,864

Proceeds of 2011 share issue

912

267

Repurchase and cancellation of shares

(242)

(104)

Dividends paid - revenue

(792)

(228)

Dividends paid - capital

(1,190)

(1,291)

Closing Shareholders' funds

26,662

24,964

 

 

 

 

 

Maven Income and Growth VCT PLC

Balance Sheet

As at 29 February 2012

29 February 2012

28 February 2011

 £'000

 £'000

 £'000

 £'000

Investments at fair value through profit or loss

25,328

 

21,395

Current assets

Debtors

923

590

Cash and overnight deposits

1,074

3,166

1,997

3,756

Creditors

Amounts falling due within one year

663

187

Net current assets

1,334

3,569

Net assets

26,662

24,964

Capital and reserves

Called up share capital

3,927

3,825

Share premium account

1,142

381

Capital reserve - realised

(7,657)

(4,733)

Capital reserve - unrealised

1,308

(2,568)

Special distributable reserve

27,455

27,697

Capital redemption reserve

70

21

Revenue reserve

417

341

Net assets attributable to Shareholders

26,662

24,964

Net asset value per

Ordinary Share (pence)

67.9

65.3

 

 

 

 

 

 

Maven Income and Growth VCT PLC

Cash Flow Statement

For the year ended 29 February 2012

29 February 2012

28 February 2011

£'000

£'000

£'000

£'000

Operating activities

Investment income received

1,141

773

Deposit interest received

12

14

Investment management fees paid

(397)

(65)

Secretarial fees paid

(60)

(59)

Directors' expenses paid

(61)

(61)

Other cash payments

(108)

(214)

Net cash inflow from operating activities

527

388

Taxation

Corporation tax paid

(3)

(174)

(3)

(174)

Financial investment

Purchase of investments

(4,243)

 (3,662)

Sale of investments

2,939

3,331

Net cash outflow from financial investment

 (1,304)

 (331)

Equity dividends paid

 (1,982)

(1,519)

Net cash outflow before financing

(2,762)

(1,636)

Financing

Issue of Ordinary Shares

912

2,131

Repurchase of Ordinary Shares

(242)

(104)

Net cash inflow from financing

670

 2,027

(Decrease)/increase in cash

 (2,092)

391

 

Notes

 

Accounting Policies - UK Generally Accepted Accounting Practice

 

(a) Basis of preparation

 

The Financial Statements have been prepared under the historical cost convention, modified to include the revaluation of investments, and in accordance with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the SORP) issued in January 2009.

 

The disclosures on Going Concern in the Directors' Report on page 27 form part of these Financial Statements.

 

(b) Income

 

Dividends receivable on equity shares and unit trusts are treated as revenue for the period on an ex-dividend basis. Where no ex-dividend date is available dividends receivable on or before the year end are treated as revenue for the period. Provision is made for any dividends not expected to be received. The fixed returns on debt securities and non-equity shares are recognised on a time apportionment basis so as to reflect the effective interest rate on the debt securities and shares. Provision is made for any fixed income not expected to be received. Interest receivable from cash and short term deposits and interest payable are accrued to the end of the year.

 

(c) Expenses

 

All expenses are accounted for on an accruals basis and charged to the income statement. Expenses are charged through the revenue account except as follows:

 

·; expenses which are incidental to the acquisition and disposal of an investment are charged to capital; and

·; expenses are charged to realised capital reserves where a connection with the maintenance or enhancement of the value of the investments can be demonstrated. In this respect the investment management fee has been allocated 20% to revenue and 80% to realised capital reserves to reflect the Company's investment policy and prospective income and capital growth.

 

(d) Taxation

 

Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or right to pay less tax in the future have occurred at the balance sheet date. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the Company's taxable profits and its results as stated in the Financial Statements which are capable of reversal in one or more subsequent periods.

 

Deferred tax is measured on a non-discounted basis at the tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted, or substantively enacted, at the balance sheet date.

 

The tax effect of different items of income/gain and expenditure/loss is allocated between capital reserves and revenue account on the same basis as the particular item to which it relates using the Company's effective rate of tax for the period.

 

UK Corporation tax is provided at amounts expected to be paid/recovered using the tax rates and laws that have been enacted, or substantively enacted, at the balance sheet date.

 

(e) Investments

 

In valuing unlisted investments the Directors follow the criteria set out below. These procedures comply with the revised

International Private Equity and Venture Capital Valuation Guidelines (IPEVCV) for the valuation of private equity and venture capital investments. Investments are recognised at their trade date and are designated by the Directors as fair value through profit and loss. At subsequent reporting dates, investments are valued at fair value, which represents the Directors' view of the amount for which an asset could be exchanged between knowledgeable and willing parties in an arm's length transaction. This does not assume that the underlying business is saleable at the reporting date or that its current shareholders have an intention to sell their holding in the near future.

 

A financial asset or liability is generally derecognised when the contract that gives rise to it is settled, sold, cancelled or expires.

 

 

 

1. For investments completed within the 12 months prior to the reporting date, and those at an early stage in their development, fair value is determined using the Price of Recent Investment Method except that adjustments are made when there has been a material change in the trading circumstances of the company or a substantial movement in the relevant sector of the stock market.

 

2. Whenever practical, recent investments will be valued by reference to a material arm's length transaction or a quoted price.

 

3. Mature companies are valued by applying a multiple to their fully taxed prospective earnings to determine the enterprise value of the company.

 

3.1 To obtain a valuation of the total ordinary share capital held by management and the institutional investors, the value of third party debt, institutional loan stock, debentures and preference share capital is deducted from the enterprise value. The effect of any performance related mechanisms is taken into account when determining the value of the ordinary share capital.

 

3.2 Preference shares, debentures and loan stock are valued using the Price of Recent Investment Method. When a redemption premium has accrued, this will only be valued if there is a reasonable prospect of it being paid. Preference shares which carry a right to convert into ordinary share capital are valued at the higher of the Price of Recent Investment Method basis and the price/earnings basis, both described above.

 

4. Where there is evidence of impairment, a provision may be taken against the previous valuation of the investment.

 

5. In the absence of evidence of a deterioration, or strong defensible evidence of an increase in value, the fair value is determined to be that reported at the previous balance sheet date.

 

6. All unlisted investments are valued individually by the portfolio management team of Maven Capital Partners UK LLP. The resultant valuations are subject to detailed scrutiny and approval by the Directors of the Company.

 

7. In accordance with normal market practice, investments listed on the Alternative Investment Market or a recognised stock exchange are valued at their bid market price.

 

(f) Fair value measurement

 

Fair value is defined as the price that the Company would receive upon selling an investment in a timely transaction to an independent buyer in the principal or the most advantageous market for the investment. A three-tier hierarchy has been established to maximise the use of observable market data and minimise the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk, for example, the risk inherent in a particular valuation technique used to measure fair value including such a pricing model and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity.

 

Unobservable inputs are inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on best information available in the circumstances

 

The three-tier hierarchy of inputs is summarised in the three broad levels listed below:

 

·; Level 1 - quoted prices in active markets for identical investments;

 

·; Level 2 - other significant observable inputs (included quoted prices for similar investments, interest rates, prepayment speeds, credit risk etc); and

 

·; Level 3 - significant unobservable inputs (including the Company's own assumptions in determining the fair value of investments).

 

(g) Gains and losses on investments

 

When the Company sells or revalues its investments during the year, any gains or losses arising are credited/charged to the Income Statement.

 

 

 

 

 

Movement in reserves

 

Share

premium account

Capital reserve - realised

Capital reserve - unrealised

Special distributable reserve

Capital redemption reserve

Revenue reserve

£'000

£'000

£'000

£000

£000

£'000

At 1 March 2011

381

(4,733)

(2,568)

27,697

21

341

Losses on sales of investments

-

(1,240)

-

-

-

-

Net increase in value of investments

-

-

3,876

-

-

-

Investment management fees

-

(653)

-

-

-

-

Dividends paid

 -

(1,190)

-

-

-

(792)

Tax effect of capital items

-

159

-

-

-

-

Repurchase and cancellation of shares

-

-

-

(242)

49

-

Share issue - 5 April 2011

609

-

-

-

-

-

Share issue - 3 May 2011

152

-

-

-

-

-

Net return on ordinary activities after taxation

-

-

-

-

-

868

At 29 February 2012

1,142

(7,657)

1,308

27,455

70

417

 

Earnings per share

 

The returns per share are based on the following figures:

 

Year ended

Year ended

29 February 2012

28 February 2011

£'000

£'000

Weighted average number of Ordinary Shares in issue

39,408,099

 

37,682,987

Revenue return

£868,000

£351,000

Capital return

£2,142,000

£2,308,000

Total return

£3,010,000

£2,659,000

 

Net asset value per Ordinary Share

 

Net asset value per Ordinary Share as at 29 February 2012 has been calculated using the number of Ordinary Shares in issue at that date of 39,265,962 (2011: 38,249,033).

 

Principal risks and uncertainties

 

The principal risks facing the Company relate to its investment activities and include market price, interest rate and liquidity risk.

 

Additional risks faced by the Company, and the mitigation approach adopted by the Board, are as follows:

 

·; investment objective: the Board's aim is to maximise absolute returns to Shareholders while managing risk by ensuring an appropriate diversification of investments;

 

·; investment policy: inappropriate stock selection leading to underperformance in absolute and relative terms is a risk which the Manager mitigates by operating within investment guidelines and regularly monitoring performance against the peer group. The regulations affecting Venture Capital Trusts are central to the Company's investment policy;

 

·; discount volatility: due to the lack of liquidity in the secondary market, venture capital trust shares tend to trade at discounts to net asset values; and

 

·; regulatory risk: the Company operates in a complex regulatory environment and faces a number of related risks. A breach of Section 274 of the Income Tax Act 2007 could result in the Company being subject to capital gains tax on the sale of its investments. A breach of the VCT Regulations could result in the loss of VCT status and consequent loss of tax reliefs currently available to Shareholders. A serious breach of other regulations, such as the UKLA Listing Rules or the Companies Act, would lead to suspension of its shares from the Stock Exchange, loss of VCT status and reputational damage. The Board receives quarterly reports from the Manager in order to monitor compliance with regulations.

 

At least twice each year the Board considers all of the above risks and the measures in place to manage them.

 

 

Other information

 

The Annual General Meeting will be held on 12 July 2012, commencing at 12.00 noon.

 

This Announcement has been prepared on the same basis as the Annual Report and Financial Statements for the year ended 28 February 2011. The Annual Report and Financial Statements for the year ended 29 February 2012 will be submitted to the National Storage Mechanism and be available for inspection at: www.Hemscott.com/nsm.do, and will also be filed with the Registrar of Companies and issued to Shareholders in due course. 

 

The financial information contained within this Announcement does not constitute the Company's statutory Financial Statements as defined in the Companies Act 2006. The statutory Financial Statements for the year ended 28 February 2011 have been delivered to the Registrar of Companies and contained an audit report which was unqualified and did not constitute statements under S498(2) or S498(3) of the Companies Act 2006.

 

Copies of this announcement, and of the Annual Report and Financial Statements Annual Report and Financial Statements for the year ended 29 February 2012, will be available to the public at the office of Maven Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow G2 52LW; at the registered office of the Company, 9-13 St Andrew Street, London EC4A 3AF and on the Company's website at www.mavencp.com/migvct.

 

Neither the content of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

Directors' responsibility statement

 

The Directors confirm that, to the best of their knowledge:

 

·; the Financial Statements have been prepared in accordance with the applicable accounting standards and give a true and fair view of the assets, liabilities and financial position of the Company as at 29 February 2012 and for the year to that date; and

 

·; the Directors' Report includes a fair review of the development and performance of the Company, together with a description of the principal risks and uncertainties that it faces.

 

By Order of the Board

 

Maven Capital Partners UK LLP

Secretary

 

7 June 2012

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SSAFMWFESESM
Date   Source Headline
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM
7th Jun 20234:21 pmRNSAnnual Financial Report
2nd Jun 20239:39 amRNSIssue of Equity
1st Jun 202312:18 pmRNSNet Asset Value(s)
26th May 20233:53 pmRNSTransaction in Own Shares
24th May 202310:52 amRNSUnaudited NAV and Proposed Final Dividend
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
5th Apr 202312:33 pmRNSDirector/PDMR Shareholding
5th Apr 202312:26 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
3rd Mar 202310:37 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 202310:35 amRNSDirector/PDMR Shareholding
3rd Mar 20239:47 amRNSIssue of Equity
21st Feb 20234:39 pmRNSTransaction in Own Shares
6th Feb 20234:23 pmRNSNet Asset Value(s)
2nd Dec 20229:30 amRNSIssue of Equity
25th Nov 202212:36 pmRNSStatement re Dividend Investment Scheme
9th Nov 20222:34 pmRNSResult of General Meeting
4th Nov 202211:15 amRNSHalf-year Report
26th Oct 20223:50 pmRNSTransaction in Own Shares
14th Oct 20223:33 pmRNSNet Asset Value and Interim Dividend
7th Oct 20224:28 pmRNSPublication of a Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.